| Dr Matthew Balls, DO | |
|
117 E Main St Ste A100, Payson, AZ 85541-4606 | |
| (289) 596-4500 | |
| Not Available |
| Full Name | Dr Matthew Balls |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | 117 E Main St Ste A100, Payson, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841784428 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 009213 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Payson Medical Center | Payson, AZ | Hospital |
| Banner Baywood Medical Center | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bhsm Rehabilitation Llc | 2062773138 | 1258 |
News Archive
Although sex education remains a taboo issue in much of China, some approaches to the subject recently have started to change and some schools have begun to teach the subject several times annually, the Washington Post reports.
EKF, announces today that the Quo-Test, its glycated haemoglobin analyser for near-patient monitoring of diabetes will be on show at Heart UK.
Abbott announced today that the U.S. Food and Drug Administration has approved AndroGel 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose compared to AndroGel 1%.
Merging technological innovations and new knowledge about basic cancer biology, cancer researchers now target specific molecules involved in critical chemical pathways of cancerous cells.
Curis, Inc., an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology as well as companion diagnostics, today announced presentation of data for Debio 0932 at the Annual Meeting of the American Association for Cancer Research (AACR) that demonstrated synergy between Debio 0932 and various standard of care (SOC) agents in multiple in vitro and xenograft models of non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC).
› Verified 7 days ago
| Entity Name | Banner Primary Care Physicians Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417238908 PECOS PAC ID: 6406020155 Enrollment ID: O20111115000898 |
News Archive
Although sex education remains a taboo issue in much of China, some approaches to the subject recently have started to change and some schools have begun to teach the subject several times annually, the Washington Post reports.
EKF, announces today that the Quo-Test, its glycated haemoglobin analyser for near-patient monitoring of diabetes will be on show at Heart UK.
Abbott announced today that the U.S. Food and Drug Administration has approved AndroGel 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose compared to AndroGel 1%.
Merging technological innovations and new knowledge about basic cancer biology, cancer researchers now target specific molecules involved in critical chemical pathways of cancerous cells.
Curis, Inc., an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology as well as companion diagnostics, today announced presentation of data for Debio 0932 at the Annual Meeting of the American Association for Cancer Research (AACR) that demonstrated synergy between Debio 0932 and various standard of care (SOC) agents in multiple in vitro and xenograft models of non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Balls, DO 1522 E A St, Casper, WY 82601-2217 Ph: () - | Dr Matthew Balls, DO 117 E Main St Ste A100, Payson, AZ 85541-4606 Ph: (289) 596-4500 |
News Archive
Although sex education remains a taboo issue in much of China, some approaches to the subject recently have started to change and some schools have begun to teach the subject several times annually, the Washington Post reports.
EKF, announces today that the Quo-Test, its glycated haemoglobin analyser for near-patient monitoring of diabetes will be on show at Heart UK.
Abbott announced today that the U.S. Food and Drug Administration has approved AndroGel 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose compared to AndroGel 1%.
Merging technological innovations and new knowledge about basic cancer biology, cancer researchers now target specific molecules involved in critical chemical pathways of cancerous cells.
Curis, Inc., an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology as well as companion diagnostics, today announced presentation of data for Debio 0932 at the Annual Meeting of the American Association for Cancer Research (AACR) that demonstrated synergy between Debio 0932 and various standard of care (SOC) agents in multiple in vitro and xenograft models of non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC).
› Verified 7 days ago
Mr. Michael Keene Demack, PA C S Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 806 S Ponderosa St, Payson, AZ 85541 Phone: 928-468-8603 Fax: 928-468-8625 | |
James W Schouten, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 708 Coeur D'alene, Payson, AZ 85541 Phone: 928-474-5259 Fax: 925-472-8832 | |
Dr. Kevin Kyle Raymer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 126 E Main St Ste B, Payson, AZ 85541 Phone: 928-472-4675 Fax: 928-472-3431 | |
Jennifer Dumbolton, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 122 E Main St, Payson, AZ 85541 Phone: 928-474-2888 Fax: 928-474-2992 | |
Debbie Alaina Mcginn, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 117 E Main St Ste 100, Payson, AZ 85541 Phone: 928-596-4500 | |
Michael Paul Lowe, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 903 E. Hwy. 260, Suite #2, Payson, AZ 85541 Phone: 928-468-2100 Fax: 928-474-7415 | |
Dr. John Howard Dumbolton, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 306 N Pioneer Trl, Payson, AZ 85541 Phone: 928-468-2195 |